Amino Acids Infusion bulk supplier for pharma manufacturers

Amino Acids Infusion 5%, 8.5%, 10%, 15% solutions Suppliers & Bulk Manufacturers

Available Forms: Intravenous (IV) Infusion Solutions

Available Strengths: 5%, 8.5%, 10%, 15% solutions

Reference Brands: Aminosyn®, Travasol®(US); Aminoplasmal®, Vamin®(EU)

Amino Acids Infusions (5%–15%) are vital IV nutrition solutions for critically ill and malnourished patients. Available in 250–1000 mL bags, top brands include Aminosyn®, Travasol®, and Aminoplasmal®. Pharma B2B suppliers ensure bulk, high-quality sourcing of amino acid infusions for hospitals, ICUs, and nutrition therapy providers globally.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Amino Acids Infusion solutions are essential components of parenteral nutrition, supporting protein synthesis, tissue repair, and metabolic function in critically ill or malnourished patients. Available in 5% to 15% concentrations, these sterile IV infusions are supplied in 250 mL to 1000 mL bags or bottles. Leading global brands include Aminosyn®, Travasol®, Aminoplasmal®, and Vamin®, produced by Baxter, B. Braun, Fresenius Kabi, and Pfizer. Amino acid infusions are crucial in ICU, oncology, surgical recovery, and long-term nutrition support. Pharma B2B platforms facilitate bulk sourcing and reliable global supply of amino acid infusion products to meet hospital and clinical nutrition demands.

Amino Acids Infusion — third party manufacturing & bulk supply

Amino Acids Infusion 5%, 8.5%, 10%, 15% solutions is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Amino Acids Infusion is supplied as Intravenous (IV) Infusion Solutions — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Amino Acids Infusion listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Amino Acids Infusion →

Back to Listing

Frequently Asked Questions

Amino Acids Infusion is used as part of parenteral nutrition to provide essential and non-essential amino acids to patients who cannot obtain adequate nutrition through oral or enteral routes. It supports protein synthesis, tissue repair, wound healing, and overall nutritional status in critically ill, postoperative, malnourished, or hospitalized patients.

Amino Acids Infusion is composed of a sterile solution containing a balanced mixture of essential and non-essential amino acids dissolved in water for injection. Some formulations may also include electrolytes, depending on clinical requirements.

Common trade names vary by region and formulation and may include Aminoven, TrophAmine, Aminoplasmal, and other hospital-based parenteral nutrition brands.

Amino acid infusion products are manufactured by multiple pharmaceutical companies globally, including Fresenius Kabi, Baxter, B. Braun, and other approved parenteral nutrition manufacturers.

The generic name is Amino Acids Injection or Amino Acids Intravenous Infusion, depending on the formulation.

Brand names vary depending on composition and region, such as Aminoven, TrophAmine, and Aminoplasmal.

Amino acid infusion products are manufactured in GMP-approved facilities across the United States, Europe, Asia, and other regions, depending on the marketing authorization holder and brand.